申请人:Merck & Co., Inc.
公开号:US20040063942A1
公开(公告)日:2004-04-01
Compounds of general structural formula I such as that shown in structural formula II
1
are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.
通用结构式I所示的化合物,如结构式II1所示,是选择性的NPY Y5受体拮抗剂,可用于治疗肥胖及其相关并发症。